A case of recurrent HPV-related disease of the lower genital tract and microinvasive vulvar cancer was followed by groin metastasis.

Genital fixed drug eruption should be considered in the presence of any acute or recurrent vulvitis.

In training medical practitioners interested in vulvovaginal diseases, there was a bias towards miniclinical evaluation exercises and direct observation as methods of assessment.

Phase-contrast microscopy of wet preparations from symptomatic women showed 2 patterns of altered vaginal flora that are not recognized in the current classification system of vaginitis.

Chronic hidradenitis suppurativa of the genital and perianal regions may be associated with cancer.

Gabapentin appears to be very effective in the treatment of generalized vulvodynia, unprovoked, and has a very low side effect profile.

Vulvodynia can be considered a somatoform disorder affecting the vulva, and any patient with it should always be investigated from a sexual and psychodynamic point of view.

 

 

Since the prevalence of heart disease and hypertension is increased in postmenopausal women, gynecologists need to be aware of these risks and recognize cardiovascular problems in their patients.

This review of the role of aldosterone in the pathophysiology of hypertension and heart disease supports the advantages of blocking the mineralocorticoid receptor with antialdosterone agents.

The combination of drospirenone and 17?-estradiol provides effective and safe relief from menopausal symptoms and has a beneficial effect on blood pressure and weight gain.

Antialdosterone-containing hormonal therapy (HT) offers postmenopausal women advantages beyond simply the relief of menopausal symptoms; drospirenone/estradiol therapy has the theoretical advantage of modulating postmenopausal cardiovascular target organ complications and represents an attractive alternative to other forms of HT.